Search clinical trials for: Placebo for Aprepitant PFS

Total 2598 results

Pfizer

Completed

Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell Disease

Phase 1 Sickle Cell

United States, United Kingdom, Belgium, Netherlands, Italy
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of BEA 2180 BR in Healthy Male Volunteers

Healthy
Erasmus Medical Center
Dutch Cancer Society

Not yet recruiting

Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL (VulVaccin)

HPV | Vulvar HSIL

Netherlands
Ascendis Pharma A/S

Active, not recruiting

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism (PaTH Forward)

Endocrine System Diseases | Parathyroid Diseases | Hypoparathyroidism

United States, Canada, Denmark, Germany, Italy, Norway
Idorsia Pharmaceuticals Ltd.

Completed

A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body

Healthy Subjects

United States
ALK-Abelló A/S

Completed

A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)

Conjunctivitis | Rhinitis Allergic
Sanofi

Recruiting

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo (HYDRO)

Dermatitis Atopic

Canada, United States
Seres Therapeutics, Inc.

Terminated

A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis (ECO-RESET)

Ulcerative Colitis

United States, Canada
AbbVie

Completed

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) (SLEek)

Systemic Lupus Erythematosus (SLE)

United States, Argentina, Australia, Bulgaria, Canada, China, Colombia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Puerto Rico, Spain, Taiwan, United Kingdom
AbbVie
Boehringer Ingelheim

Completed

BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)

Pneumonia, Pneumococcal

United States
Korean Society for Sexual Medicine and Andrology

Completed

Efficacy and Safety of DA-9401 on Improvement of Sperm Motility

Spermatocele

Korea, Republic of
Nestlé

Completed

Daily Protein Intake Distribution and MPS (ARCIII)

Overweight
Pfizer

Completed

Efficacy Study Of Tofacitinib In Pediatric JIA Population

Juvenile Idiopathic Arthritis

United States, Spain, Turkey, Canada, Australia, Israel, United Kingdom, Argentina, Brazil, Poland, Mexico, Belgium, Russian Federation, Ukraine
Boehringer Ingelheim

Completed

Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809

Healthy

Germany
SK Chemicals Co., Ltd.

Completed

Clinical Trial to Evaluate Efficacy and Safety of SID142 in Patients With Chronic Artery Occlusive Disease

Peripheral Arterial Disease

Korea, Republic of
Novartis

Completed

Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus (ViVID)

Hypertension

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

HIV Infections

United States, Malawi, Brazil, South Africa
GlaxoSmithKline

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.

Psoriasis

United Kingdom
Xequel Bio, Inc.

Completed

Study to Evaluate the Safety of FSR Peptide Versus Placebo Following Punch Biopsy

Wound Heal

Switzerland
Merck Sharp & Dohme LLC

Completed

A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)

Postoperative Nausea and Vomiting | Chemotherapy-Induced Nausea and Vomiting
Pharmanex
Dermatology Consulting Services, High Point NC

Not yet recruiting

Study to Assess Impact of Dietary Supplement on Sleep Health

Sleep
National Institute of Allergy and Infectious Diseases...
GlaxoSmithKline; Rho Federal Systems Division, Inc.; Inner-City Asthma Consortium

Completed

A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children (MUPPITS-2)

Asthma

United States
Vivek Jain
George Washington University

Recruiting

Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine

Sleep Apnea, Obstructive | Sleep Apnea

United States
University of Washington
GlaxoSmithKline; Asociación Civil Impacta Salud y Educación, Peru

Completed

HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected Persons

HIV Infections | Sexually Transmitted Diseases | Herpes Simplex

Peru
Hospital General de México Dr. Eduardo Liceaga

Completed

Serum Insulin Response After Acute and Chronic Sucralose Ingestion in Healthy Volunteers With Variable Body Mass Index

Healthy
University of Toronto
Canadian Institutes of Health Research (CIHR)

Completed

The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis

Osteoporosis

Canada
University of Newcastle, Australia
Queen Margaret University

Completed

Foot Orthoses (FOs) on Pain, Quality of Life and the Gait With Children Diagnosed With JIA

Arthritis, Juvenile Rheumatoid

Australia
Janssen Research & Development, LLC

Completed

A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab (NAVIGATE)

Psoriasis

United States, Poland, United Kingdom, Germany, Taiwan, Spain, Australia, Canada, Korea, Republic of, Russian Federation
Massachusetts General Hospital
Genentech, Inc.

Completed

Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

Anorexia Nervosa | Osteoporosis | Osteopenia | Eating Disorders

United States
Hugh A Sampson, MD
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

OIT and Xolair® (Omalizumab) in Cow's Milk Allergy

Milk Allergy

United States
Government Dental College and Research Institute...
Himalaya Drug Company Ltd. India

Completed

Clinical and Microbiological Efficacy of Systemic Ayurvedic Immunomodulator Septilin in the Treatment of Chronic Periodontitis

Chronic Periodontitis

India
National Institute of Allergy and Infectious Diseases...
Atopic Dermatitis Research Network

Terminated

Targeted Investigation of Microbiome Elimination (TIME-1)

Atopic Dermatitis

United States
Lawson Health Research Institute
St. Joseph's Health Care London; The W. Garfield Weston Foundation; Parkwood...

Completed

Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction

Spinal Cord Injuries | Neurogenic Bowel | Bladder Dysfunction

Canada
AbbVie

Terminated

A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib

Rheumatoid Arthritis (RA)

Belgium, Canada, Czechia, Hungary, Poland, Spain, United Kingdom
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
Indiana University
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Erenumab-aooe in Patients With Temporomandibular Disorder

Temporomandibular Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...
Bayer

Completed

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

Stroke | Embolism | Atrial Fibrillation

United States, Australia, France, Poland, Ukraine, United Kingdom, China, Belgium, Germany, Taiwan, Spain, Argentina, Colombia, Israel, Mexico, Bulgaria, India, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic... and more
Auro Vaccines LLC
United States Department of Defense; Accelovance

Completed

Trial to Evaluate Safety and Immunogenicity of an Ebola Zaire Vaccine in Healthy Adults

Ebola Virus Disease

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Novartis Pharmaceuticals; Rho Federal Systems Division, Inc.

Active, not recruiting

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants (OUtMATCH)

Peanut Allergy | Multi-food Allergy

United States
Jiangsu HengRui Medicine Co., Ltd.

Unknown

A Study of SHR0410 in Hemodialysis Patients With Pruritus

Pruritus

China
Hoffmann-La Roche

Completed

Study to Investigate the Effect of Balovaptan on the QTC Interval in Healthy Subjects

Healthy Volunteers

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates (COLT)

Liver Transplant

United States
University of Washington
National Institute of Mental Health (NIMH); Ministry of Health, Mozambique; Comité...

Recruiting

Systems Analysis and Improvement Approach to Optimize the Task-shared Mental Health Treatment Cascade (SAIA-MH) (SAIA-MH)

Mental Health Disorder

Mozambique
University of Cologne

Recruiting

Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma (DupiMorph)

Localized Scleroderma

Germany
Lianyungang Kanion Group, Ltd.

Completed

JINZHEN for Treatment of Mild to Moderate COVID-19

COVID-19

United States
Tufts University
MB Clinical Research and Consulting LLC

Completed

Vitamin and Mineral Supplementation Improves Micronutrient Status in Older Adults

Nutrient Deficiency

United States
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Phase 3, Randomized, Safety, Lot Consistency and Clinical Benefit Study of Recombinant Botulinum Vaccine A/B (rBV A/B)

Botulism
TenNor Therapeutics Inc.

Completed

Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants

Acute Bacterial Skin and Skin Structure Infection (ABSSSI) | Prosthetic Joints Infection (PJI)

China
Biogen

Completed

Long-Term Assessment of Remyelinating Therapy (RENEWED)

Acute Optic Neuritis

Sweden, Spain, United Kingdom, Germany, Canada, Denmark, Hungary, Belgium, Czechia, Australia, Italy

Search clinical trials for: Placebo for Aprepitant PFS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations